QUINLAN KEVIN W 4
4 · ANIKA THERAPEUTICS INC · Filed Feb 4, 2008
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Award
Stock Appreciation Rights
2008-01-31+20,570→ 20,570 totalExercise: $10.99Exp: 2018-01-31→ Common Stock (20,570 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in three equal installments annually beginning January 31, 2009.